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of Identity by Descent in Unrelated Individuals
Sharon R. Browning1,2,* and Brian L. Browning1,2
Detection of recent identity by descent (IBD) in population samples is important for population-based linkage mapping and for highly
accurate genotype imputation and haplotype-phase inference. We present a method for detection of recent IBD in population samples.
Our method accounts for linkage disequilibrium between SNPs to enable full use of high-density SNP data. We ﬁnd that our method can
detect segments of a length of 2 cMwithmoderate power and negligible false discovery rate in Illumina 550K data in Northwestern Euro-
peans. We compare our method with GERMLINE and PLINK, and we show that our method has a level of resolution that is signiﬁcantly
better than these existing methods, thus extending the usefulness of recent IBD in analysis of high-density SNP data. We survey four
genomic regions in a sample of UK individuals of European descent and ﬁnd that on average, at a given location, our method detects
IBD in 2.7 per 10,000 pairs of individuals in Illumina 550K data.We also presentmethodology and results for detection of homozygosity
by descent (HBD) and survey the whole genome in a sample of 1373 UK individuals of European descent. We detect HBD in 4.7 indi-
viduals per 10,000 on average at a given location. Our methodology is implemented in the freely available BEAGLE software package.Introduction
Identity by descent (IBD) is fundamental to genetics. Two
individuals are identical by descent (IBD) at a locus if
they share identical genetic material inherited from
a common ancestor. Analysis of IBD in pedigree data is
important for linkage mapping. In small pedigrees, indi-
viduals are closely related and segments of IBD tend to
be fairly long (> 10 cM) and are easily detected with the
use of dense microsatellite or SNP marker panels. Large
pedigrees from founder populations have been more difﬁ-
cult to analyze, partly because the segments of IBD can
become quite small, but also because simultaneous anal-
ysis of all markers and all individuals is computationally
intractable.
The concept of IBD is also important for population
genetics, where it is approached quite differently. Whereas
IBD in a pedigree is of recent origin, in a population-
genetics perspective most IBD will be extremely ancient.
For SNPs that have not experienced recurrent mutation,
identical alleles are IBD in the population-genetics sense.
Such IBD segments will tend to be extremely short,
perhaps covering only a single polymorphism or, at
most, a few kilobases of DNA. The population-genetics
concept of IBD underlies association testing and GWAS.
It is useful to consider an intermediate deﬁnition of IBD.
A pair of individuals may not know of any relationship
between them, yet they may be, for example, twentieth
cousins. In general, IBD segments due to sharing from a
common ancestor n generations in the past (hence
involving 2nmeiosis) have expected length 1/(2n)Morgans
(M).1 Thus, twentieth cousins, who have common ancestry
21 generations in the past, have IBD segments of average
length 1/42 M, or 2.3 cM. We show that IBD segments of1Department of Statistics, University of Auckland, Auckland, New Zealand
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European descent with dense SNP data and our proposed
methodology. As an alternative to the pedigree-based and
population-genetics deﬁnitions of IBD, we consider ‘‘recent
IBD,’’ in which individuals are IBD at a locus if they share
an identical haplotype at the locus and the extent of sharing
is greater than would be expected by chance, given the
populationhaplotype frequencies. Thus, unlike thepopula-
tion-genetics deﬁnition of IBD, the deﬁnition that we are
using involves recent shared inheritance and sharing that
extends beyond the background level of linkage disequilib-
rium (LD). We ﬁnd that our method has moderate power
to detect IBD segments 2 cM in length. Hence, the target
range of shared ancestry with ourmethod is up to 25 gener-
ations ago.
Because of its fundamental role in genetics, IBDhasmany
uses. One application of recent IBD is population-based
linkage analysis,2 also known as IBD mapping.3,4 IBD
mapping is similar to linkage mapping, except that IBD
mapping does not require pedigree information. One looks
for greater levels of IBD sharing in case-case pairs than in
case-control or control-control pairs. IBD mapping could
prove useful in mapping disease-susceptibility genes with
allelic heterogeneity (e.g., multiple rare causal variants)
that are difﬁcult to map with association analysis. It is
easier and less expensive to collect population samples
than to collect families for a traditional linkage analysis.
Also, population samples have the advantage of represent-
ing, in essence, very extended pedigrees, which have power
advantages over small pedigrees.5 Similarly, one can use
homozygositybydescent (HBD) tomap rare recessivemuta-
tions of strong effect.
Another application of recent IBD is genotype-imputa-
tion and haplotype-phase inference.6 Comparison ofGenetics. All rights reserved.
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Table 1. Four Genomic Regions Selected for Evaluation of IBD Detection
Region Chromosome
Build 35
Position (Mb)
Genetic
Position (cM)
Affymetrix 500K
Markers/cM
Illumina 550K
Markers/cM
Combined
Markers/cM
1A 1 5.8–14.0 15–30 54 94 136
1B 1 180.7–188.1 200–205 208 205 390
2A 2 5.1–11.1 10–25 76 91 153
2B 2 50.4–56.3 75–80 201 276 441
The table shows the position of each region and the density of SNPs in each of the two panels plus the density of SNPs in the union of the two panels.imputation and phasing accuracy in unrelated individuals
and parent-offspring trios shows that the use of IBD data
can substantially reduce switch-error rates and imputa-
tion-error rates.7 Recently, Kong et al.6 showed that
exceptionally accurate phasing is possible when multiple
individuals have inherited a genomic segment identically
by descent. IBD can also be used to detect phasing errors
and structural variants.8
Several methods have been proposed for detection of
recent IBD and HBD. One IBD detection criterion is the
length of segment over which genotypes are compatible
with IBD or HBD.6,9–14 For diallelic SNPmarkers, genotypes
are compatible with IBD unless the two individuals have
discordant homozygous genotypes. Thus, long stretches
of IBD compatibility are needed before recent IBD can be
declared with conﬁdence. Typically, the length threshold
used is 5–10 Mb or 5–10 cM. One variant of this approach
is the GERMLINE program,8 which considers identity of
haplotypes rather than of genotypes. The advantage of
using haplotypes is that two haplotypes are less likely
than two genotypes to be consistent with IBD by chance.
The disadvantage of using haplotypes is that sensitivity to
detect IBD strongly depends on accurate haplotype infer-
ence because phase uncertainty is not modeled. One
notable feature of the GERMLINE software is its high
computational efﬁciency. In general, searching for IBD
between all pairs of individuals in a sample has computa-
tional time that is quadratic in the number of individuals.
However, the GERMLINE software is able to solve this
problem in linear computing time by partitioning the
genome into windows and exploiting the limited number
of distinct haplotypes observed in each window. Another
approach to detecting IBD is implemented in the PLINK
software package.2 PLINK applies a hidden Markov model
(HMM) to the IBD process, while assuming independence
(linkage equilibrium) among markers. Albrechtsen et al.4
extend thePLINKapproach to incorporateLDviahaplotype
probabilities for pairs of SNPs. Although this approach is
a clear improvementon the assumptionofnoLD,we expect
that the pairwise approach may not adequately correct for
LD in some genomic regions with high levels of LD.
The method that we present for detecting IBD in ‘‘unre-
lated’’ individuals accounts for background levels of LD by
using a comprehensive LD model incorporating data from
all markers in a region. Fully accounting for LD is impor-The Amtant, because in regions of high LD many pairs of individ-
uals will share common haplotypes, which are not really
‘‘IBD’’ in the sense deﬁned here (i.e., inherited from a recent
common ancestor). Thus, including such spurious IBD
would add noise when one is looking for recent IBD for
the purpose of IBD mapping or improved haplotype phase
inference. Incorporation of a comprehensive LD model
reduces false-positive IBD detection, thus giving the ability
to identify much smaller IBD segments. An alternative
approach to dealing with LD is to prune markers, which
is the approach taken by PLINK.2 However, we show that
this approach leads to decreased power to detect short
segments of IBD.Material and Methods
Data
We analyzed genotype data from the 1958 British Birth Cohort
(58BC).15 We used a prerelease version of BEAGLECALL16 to call
SNP genotypes from allele signal-intensity data from the Affyme-
trix 500K chip and the Illumina 550K chip generated by the Well-
come Trust Case Control Consortium17 and the Wellcome Trust
Sanger Centre as described previously.16 BEAGLECALL utilizes
LD as well as the allele signal intensities to obtain high geno-
type-call accuracy. After calling genotypes, all genotypes with
posterior probability < 0.985 for Illumina or < 0.975 for Affyme-
trix were set to missing, and all SNPs with missing data rate
> 0.015 for Ilumina or > 0.025 for Affymetrix were excluded.
Also, SNPs withminor allele frequency< 0.01 were excluded. After
ﬁltering, there were 399,651 autosomal SNPs in the Affymetrix
data and 511,942 autosomal SNPs in the Illumina data. 1373 indi-
viduals that passed light data quality ﬁlters16,17 and that were gen-
otyped on both platforms were included in the analyses.
As it is not yet computationally feasible to apply the proposed
IBD detection method to all pairs of samples on a genome-wide
scale for large sample sizes, we selected four regions to examine
in detail. We chose two regions with a lower density of markers
and two regions with a higher density of markers, from chromo-
somes 1 and 2. Each region was chosen to contain approximately
1000 SNPs in each panel, and to cover 15 cM (low-density regions,
1A and 2A) or 5 cM (high-density regions, 1B and 2B). Details of
these regions are shown in Table 1. Estimates of genetic distance
are taken from HapMap Phase 2.18
Calculation of IBD Probabilities
Our approach to calculating IBD probabilities for phased haplo-
types has been outlined previously.1 Extending this to unphasederican Journal of Human Genetics 86, 526–539, April 9, 2010 527
genotypes is nontrivial, because it is necessary to simultaneously
perform IBD probability calculation and haplotype phasing in
order to account for haplotype-phase uncertainty.
In order to calculate IBD probabilities on dense genotype data,
one needs to model both LD between markers and IBD between
individuals. Thus, themodel underlying the IBD probability calcu-
lation is a hidden Markov model (HMM) comprising two con-
nected parts: an IBD model and an LD model.
The IBD model has two states: IBD (1) and non-IBD (0). When
calculating the probability of IBD between two individuals at
a locus, we ignore the possibility that one or both of the individ-
uals may be inbred and hence HBD at the locus (this assumption
can be checked in advance), and we also ignore the possibility
that individualsmay be bilinearly related (i.e., that each individual
is related to the other through both their mother and their father,
as, for example, siblings are). Although ‘‘unrelated’’ individuals
may be distantly related through more than one pair of parents,
it is unlikely that they will be IBD through more than one pair
of parents at the same locus.
The IBD model is Markov. This is an approximation that has
previously been used successfully in inferring relationships,19 esti-
mating HBD,20 and estimating inbreeding coefﬁcients.21
The prior probabilities that we use for the IBDmodel for a pair of
individuals are: IBD at a locus with probability 0.0001, and 1 cM
expected IBD tract length. Equivalently, the transition rate from
IBD to non-IBD (t10) is 1 per cM, whereas the transition rate
from non-IBD to IBD (t01) is 0.0001 per cM (tij is the transition
rate from IBD state i to j). In our experience, these parameters
are appropriate for samples of unrelated individuals of Northern
European ancestry (such as the 58BC data) and roughly match
the levels of IBD found in such samples (see Results).
The LD model is the localized haplotype cluster HMM imple-
mented in BEAGLE.22,23 We combine the LD and IBD model
into a single HMM as described below. Although we deﬁne the
IBD probabilities for haplotypes (rather than directly for unphased
genotypes) and the haplotype phases are unknown, the HMM
calculations integrate over all possible phasings.P
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:Consider one pair of individuals. When the IBD state is 0 (non-
IBD), the probability of the four haplotypes is found by multi-
plying the probabilities of the individual haplotypes (we assume
Hardy-Weinberg equilibrium). The probability of each of the
haplotypes is found by multiplying the corresponding transition
probabilities of the LD model. An IBD state of 1 implies one pair
of IBD haplotypes (we are excluding the possibility of more
complex IBD patterns). The haplotype phase of individuals is
unknown, but individuals’ haplotypes are stored as ordered pairs
within the algorithm. Because we have no information about
parental origin of the haplotypes (i.e., which haplotype is mater-
nally inherited and which paternally inherited), there is
symmetry; if the haplotypes for one individual are labeled (H1,
H2), then P((H1,H2)) ¼ P((H2,H1)). If individual 1 has ordered
haplotype pair (H1, H2) and individual 2 has ordered haplotype
pair (H3, H4), we deﬁne an IBD state of 1 to imply that haplotypes
H1 andH3 are IBD at the givenmarker position. If the two individ-528 The American Journal of Human Genetics 86, 526–539, April 9, 2uals have data consistent with IBD, the two putatively IBD haplo-
types will, during sampling from the posterior distribution, take
the role of the H1 and H3 haplotypes.
The probability of the set of four haplotypes is the probability of
the pair of IBD haplotypes (deﬁned next) multiplied by the prob-
abilities of the other two haplotypes (obtained from the LDmodel
as when the IBD state is 0). If the pair of IBD haplotypes pass
through the same path in the LD model (i.e., the same series of
edges22,23), the probability of the pair of haplotypes is equal to
the probability of a single haplotype obtained by multiplying
(once) the corresponding transition probabilities from the LD
model; that is, the two IBD haplotypes contribute to the overall
probability as if they were only a single haplotype. When the
two IBD haplotypes pass through different edges of the LDmodel,
the minimum of the two corresponding transition probabilities is
used. The reason for using the minimum of the two edge probabil-
ities is to avoid inﬂating the posterior probability of IBD.
To allow for possibility of genotype error, we incorporate a geno-
type-error probability 3 (we use 3 ¼ 0.005). If the (possibly
imputed) alleles of the two IBD haplotypes are not identical at
a SNP, we include a factor 3, whereas if they are identical, we
include a factor 1 3.
An HMM is deﬁned by its state space, initial probabilities, transi-
tion probabilities, and emission probabilities (probability of
observing the data given the model state). For our model of IBD
and LD, the state at each marker position is two ordered pairs of
haplotype states (one ordered pair for each of the two individuals
for whom the IBD probabilities are being computed) plus the IBD
status (i¼ 0/1). A haplotype state, e, is a localized haplotype cluster
in the LD (BEAGLE)model.We canwrite the joint LD and IBD state
as (e1,e2,e3,e4,i). The model runs along the chromosome, so the
initial probabilities are deﬁned at the ﬁrst marker position. At the
initial state, P(i ¼ 0) ¼ 1, and the remaining four components are
with initial probabilities obtained from the LD model. We intend
to change the initial IBD prior probability so that it matches the
steady-state IBD prior probability (i.e., P(i ¼ 1) ¼ t01/(t01þt10)) in
a future version of the software. The transition probabilities are:in which a1
0 and a30 are the alleles of haplotypes H1 and H3 at the
next position (corresponding to haplotype states e1
0 and e30), sij is
the probability of transitioning from IBD state i at the current
position to IBD state j at the next position (s11 ¼ exp(-t10d), s00 ¼
exp(-t01d), s10¼1 - s11, s01¼1 - s00, inwhichd is the genetic distance
between the current and next positions; these expressions assume
negligible probability of more than one change in IBD status
between two markers and are therefore appropriate for closely
spaced markers), and P(e/e0) are transition probabilities between
haplotype states (from the LD model). The emission probabilities
are derived from the BEAGLE LDmodel and are either 0 (haplotype
states not consistent with genotypes) or 1 (haplotype states consis-
tent with genotypes). This formulation is quite general and could
be used with other LD models, such as the fastPHASE model.24,25
We have experimented with using a weighted mean rather than
a minimum in the transition probabilities above. We found that
using the mean can cause false-positive IBD because when one010
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Figure 1. Example of an LD Model on Four SNPs
SNP 1 is represented by edges eA and eB; SNP 2 by edges eC, eD, eE;
SNP 3 by edges eF, eG, eH; and SNP 4 by edges eI, eJ, eK, eL. For
each SNP, allele 1 is represented by a solid line, whereas allele 2
is represented by a dashed line. Haplotype H1 (1 1 1 1) follows
the orange path (eA, eC, eF, eI), and haplotye H2 (2 1 1 1) follows
the blue path (eB, eE, eF, eI).haplotype is very rare, the difference between the IBD and non-
IBD probabilities can become very large (because the very small
haplotype probability occurs in the non-IBD probability but essen-
tially disappears into the mean in the IBD probability). As a result,
in some regions several pairs of individuals were reported to have
very small (< 0.1 cM) IBD segments. We found that using the
minimum avoids this problem. However, the transition probabil-
ities from a state should sum to 1. They do sum to 1 if the mean
is used, but not if the minimum is used (in which case they sum
to < 1). Thus, using a minimum downweights the probabilities
when the two possibly IBD haplotypes are traveling through
different paths of the model, which is useful. We plan to investi-
gate this issue further in future research.
To demonstrate these probability calculations, we give a small
example on four SNP markers (however, note that the method is
designed for dense SNP data with thousands of markers per chro-
mosome). Again, we assume that the haplotypes are known.
However, in calculating the posterior probability of IBD, the
HMM method will account for haplotype uncertainty (the full
calculation of IBD probabilities for this example is not shown).
The LD model for the four SNPs is taken from previous work23
and is shown in Figure 1. The transition probabilities for the
model are P(eA) ¼ 0.518, P(eB) ¼ 0.482, P(eC) ¼ 0.627, P(eD) ¼
0.373, P(eE) ¼ 1.0, P(eF) ¼ 0.490, P(eG) ¼ 0.510, P(eH)¼ 1.0, P(eI) ¼
0.194, P(eJ) ¼ 0.806, P(eK) ¼ 1.0, P(eL) ¼ 1.0. Individual 1 has
haplotypes H1 ¼ 1 1 1 1 and H2 ¼ 1 2 2 1; individual 2 has haplo-
types H3¼ 2 1 1 1 andH4¼ 2 1 2 2.We calculate the probability of
the four haplotypes given that haplotypes H1 and H3 are IBD at all
four marker positions.
PðH1,H2,H3,H4 jH1 and H3 are IBDÞ¼PðH2ÞPðH4ÞPðH1,H3 j IBDÞ
PðH2Þ ¼ PðeAÞPðeDÞPðeHÞPðeLÞ ¼ ð0:518Þð0:373Þð1:0Þð1:0Þ ¼ 0:193
PðH4Þ ¼ PðeBÞPðeEÞPðeGÞPðeKÞ ¼ ð0:482Þð1:0Þð0:510Þð1:0Þ ¼ 0:246
PðH1,H3 j IBDÞ ¼ minðPðeAÞ,PðeBÞÞ3minðPðeCÞ,PðeEÞÞ
 ð1 3ÞPðeFÞð1 3ÞPðeIÞð1 3Þ ¼ ð0:482Þð0:005Þð0:627Þ
 ð0:995Þð0:490Þð0:995Þð0:194Þð0:995Þ ¼ 1:413104
Finally,
PðH1,H2,H3,H4 jH1 is IBD with H3Þ
¼ ð0:193Þð0:246Þ1:413104 ¼ 6:73106:
Informally,whentheprobabilityof thedata ismuchhigherunder
IBD than under non-IBD (high enough to overcome the low prior
probability of IBD), the posterior probability of IBD will be high.
The estimation of the IBD proceeds by ﬁrst building the LD
model from the unphased genotypes by using ten iterations of
the model-building algorithm to obtain convergence.23 We then
add the IBDmodel to the LDmodel and use the forward-backward
algorithm for HMMs26,27 to obtain posterior probabilities of IBD
for each pair. Our software also reports the most likely haplotype
phasing given IBD, which can be useful for phasing related indi-
viduals. The procedure may be repeated several times with the
use of different random number seeds, with the maximum poste-
rior IBD probability from the multiple runs used. This avoids false
negatives due to the ﬁtted LD model converging to a local
maximum that does not allow the haplotypes to follow their
true IBD conﬁguration. In this study, we use ten runs for IBD prob-
abilities and ﬁve runs for HBD probabilities (see below).The AmConstructing the LDmodel takes the same amount of computa-
tional time as it would to phase the data set by using BEAGLE,
which is relatively fast.23 However, with n individuals, there are
on the order of n2 potential pairs on which to calculate IBD prob-
abilities, thus increasing the total computation time, relative to
phasing, by the order of n. Thus, it is not currently feasible to
compute IBD probabilities on all pairs of individuals over the
whole genome in a large data set with thousands of individuals.
Calculation of HBD probabilities involves only two haplotypes
(from a single individual), but the basic principle is the same.
The probability of the two haplotypes given that they are non-
HBD is found by multiplying the two haplotype probabilities
together. The probability of the two haplotypes given HBD is the
same as the probability of two haplotypes given IBD, as described
above.
For HBD, the basic unit is individuals, rather than pairs of indi-
viduals. Thus, estimating HBD probabilities for all individuals
takes only slightly longer than phasing all individuals in a data
set. We have estimated HBD probabilities on all individuals from
several case-control cohorts from theWellcome Trust Case Control
Consortium17 with approximately 5000 individuals genotyped on
400,000 autosomal SNPs, thus demonstrating that our HBD detec-
tion method can be applied to large genome-wide association
studies. Genome-wide HBD could be useful for gene mapping in
diseases with rare recessive variants of strong effect.
We deﬁne as IBD or HBD any position at which the correspond-
ing IBD or HBD probability exceeds 0.5. To deﬁne the length of an
IBD or HBD region, we measure the genetic length from the ﬁrst
position at which the pair is IBD or the individual is HBD to the
last position before the IBD or HBD probability drops below 0.5.
Comparison with Other Programs
We tested our method (implemented in BEAGLE) against GERM-
LINE version 1.4.08 and PLINK version 1.07,2 two existing state-
of-the-art programs for IBD detection. We also attempted to
include RELATE4 in our comparisons. However, we were unable
to successfully run this program. We ran GERMLINE with default
settings (a maximum of two mismatched homozygote markers
in a slice for it to be considered a match, and slice size of 128
markers), except that we adjusted theminimum length of reported
IBD segments, as described in the Results (the default is 5 cM). For
PLINK, we followed the method for pruning SNPs suggested in the
PLINK documentation for shared segment analysis (SNPs with
> 1% missing genotypes and < 5% minor allele frequency
removed, then pairwise LD-based pruning with window size 100,erican Journal of Human Genetics 86, 526–539, April 9, 2010 529
step size 25, and r2 threshold 0.2). The resulting numbers of SNPs
remaining in each region described in Table 1 were 317 in 1A,
124 in 1B, 314 in 2A, and 154 in 2B and 7103 on chromosome 1
(reduced from 39146).We used the default parameters for segment
detection (minimum 100 SNPs in a shared segment andminimum
length 1000 kb), and we also ran analyses using relaxed settings,
which were a minimum of 20 SNPs in a shared segment of length
at least 200 kb. PLINK shared-segment analysis also requires esti-
mates of kinship, which should usually be obtained from
genome-wide data. Because we were using modiﬁed data, either
with artiﬁcially inserted IBD or with composite individuals for
removal of IBD, genome-wide kinship estimates were not relevant.
Instead, we input as estimated kinship (bp) the value 0.0036, which
is the average value seen genome-wide in the 58BC data.Construction of Composite Individuals for Estimation
of False-Positive Rate
In order to estimate the false-positive rate for detected IBD, we
created composite individuals whose genotype data is composed
of a sequence of 0.2 cM segments copied from different individ-
uals. By construction, the composite individuals will not share
an IBD tract longer than 0.2 cM with any other individual in the
data set. Consequently, any detected IBD sharing involving
a composite individual that is substantially longer than 0.2 cM
will be a false positive. We use composite individuals instead of
sampled individuals to estimate the false-positive rate for IBD
detection because it is not possible to be certainwhether a detected
IBD segment in a pair of population samples is a false or a true
positive, because it is possible that the individuals sharing the
segment are distantly related.
A subset of 100 58BC individuals from the Illumina 550K chip
chromosome 1 data were selected and used to create ten composite
individuals. The 100 individuals were divided into ten sets of ten
individuals. Each set of ten samples was used to create one
composite individual as follows: First, a random offset of c cM
(0 % c < 0.2) was selected for the composite individual. Then
the samples were indexed as 1, 2, ., 10, and for K ¼ 1,2, . the
genotype data for sample ((K  1) modulo 10) þ 1 was used in
the interval from (c þ (K  2)/5) % x < (c þ (K  1)/5) cM. Thus,
the ﬁrst sample’s genotype data were used in the interval 0 %
x < c cM, the second sample’s genotype data were used in the
interval c % x < (c þ 0.2) cM, the third sample’s genotype data
were used in the interval (c þ 0.2) % x < (c þ 0.4) cM, and so
on. At the eleventh segment, the sample index wraps around to
1, and the ﬁrst sample’s genotype data are used in the interval
(c þ 1.8) % x < (c þ 2.0) cM.Construction of Artiﬁcial IBD and HBD for Estimation
of Power
In order to calculate power of IBD or HBD detection, we con-
structed artiﬁcial IBD and HBD as follows. We took the 58BC
data and added to them HapMap Phase 2 CEU phased parental
genotypes, considering only SNPs genotyped in both sets of indi-
viduals. The HapMap Phase 2 CEU genotypes are accurately
phased with the use of trio data, which allowed us to copy a haplo-
type from one individual into another to create artiﬁcial IBD of
given segment size. To create IBD, we copied a haplotype from
one parent into the other for each parent pair, whereas to create
HBD, we copied a haplotype onto the other haplotype from the
same individual. Although it was essential to have phased haplo-
types to create realistic IBD, we wished to test our method on530 The American Journal of Human Genetics 86, 526–539, April 9, 2detecting IBD in unphased genotypes, so we randomized the
genotype order to create unphased data after adding the IBD or
HBD.
We added IBD or HBD segments of lengths 1, 2, 3, 4, and 5 cM.
The starting position of the IBD or HBD segment within the region
was random, except that we avoided placing the region within
the ﬁrst or last 50 markers of the region. In total, 120 IBD
segments of each length were created (30 parent pairs times four
regions), whereas 240 HBD segments of each length were created
(60 parents times four regions). An IBD or HBD segment in a region
was scored as detected if the pair of samples sharing the segment
was reported to be IBD anywhere in the region.
Estimation of False Discovery Rates
The false discovery rate is the proportion of discovered IBD
segments that are false positives. Consider a ﬁxed interval of IBD
sizes. Let T be the true rate of IBD segments with length in this
interval in the population (all rates are per pair of individuals,
per locus). Let F be the rate at which IBD segments in this length
range are falsely predicted by the method under consideration in
pairs of individuals with no IBD. Let P be the power to detect
IBD of the speciﬁed length. Let D be the rate at which IBD
segments in this length range are discovered (including false and
true positives). In a data set with some IBD, the rate of false-posi-
tive discoveries will be ð1 TÞF (the rate of non-IBDmultiplied by
the false-positive rate) and the rate of true discoveries will be TP
(the rate of IBDmultiplied by the power). The rate of IBD discovery
includes false and true discoveries, and is thus D ¼ ð1 TÞF þ TP.
Given estimates of F, P, and D, one can solve for an estimate of T:
T^ ¼ ðD^ F^Þ=ðP^  F^Þ. The false discovery rate is estimated by
ð1 T^ÞF^=½ð1 T^ÞF^ þ T^P^. In our analyses, we estimate F and P
for each method. In particular, we consider IBD segment sizes in
the range x to xþ 1 cM for x¼ 1, 2, 3, 4. For F, we use the estimated
false-positive rate for segments of size x to x þ 1 (obtained by sub-
tracting the false-positive rate for segments with lengthR (x þ 1)
from the false-positive rate for segments with length R x).
For P, we use an average of the power to detect IBD of size x
and the power to detect IBD of size (x þ 1). We estimate D only
for the BEAGLE IBD method, using the rate of IBD detected
of size between x and xþ1 per locus, which is
D^ ¼Pi yi=ðnpairs3total lengthÞ, in which the yi are the lengths
of the detected segments that are within the size range x to x þ
1 cM, ‘‘npairs’’ is the number of pairs interrogated, and ‘‘total
length’’ is the length in cM of the interrogated region. T should
not depend on the method, and because we have estimates of D
for BEAGLE only, we use these to estimate T.Results
Estimation of IBD False-Positive Rate
We combined chromosome 1 genotype data from the Illu-
mina 550K chip for ten composite samples from the 58BC
(see Material and Methods) with1323 individuals from the
58BC cohort. The 1323 58BC samples did not include any
of the 100 individuals used to construct the ten composite
samples. We then compared three IBD-detection methods
(BEAGLE, PLINK, and GERMLINE) for this combined
sample. Results are shown in Table 2. BEAGLE’s false-posi-
tive rate is uniformly lower than that of GERMLINE and
PLINK. Although these false-positive rates are very small010
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The Amso that differences might be thought to be of no conse-
quence, they are in fact very important. The rate of true-
positive IBD signals in an outbred population sample will
also be extremely small, and thus the false-positive rate
has a large impact on the false discovery rate (proportion
of reported signals that are false), as we demonstrate below.
IBD and HBD Power
We created artiﬁcial IBD as described in Material and
Methods, and we estimated the power to detect this IBD
by using BEAGLE, GERMLINE, and PLINK. For IBD power
with BEAGLE, we investigated four regions of the genome
(see Table 1) and three panels of SNPs (Affymetrix 500K,
Illumina 550K, and the union of these two panels). From
Figure 2, we can see that power is fairly constant over the
four regions, with the low density regions (1A and 2A)
having lower power for the Affymetrix 500K data but not
for the other two SNP panels. In the 58BC data, power to
detect IBD is high for segments of size 3 cM and larger
(using the Illumina 550K panel). Power to detect segments
of size 2 cM is 50%, whereas power to detect segments of
size 1 cM is only 10%–20%. Adding the Affymetrix data
to the Illumina data does not increase power substantially
over the use of only the Illumina data. It seems that the
Illumina 550K chip already has good coverage of all
common variants. Most SNP discovery has been performed
in small samples, biasing it toward common variants, and
common variants are also favored on the SNP arrays
because they tend to have higher power in association
studies; thus, the SNP arrays have a frequency spectrum
that is biased toward common variants. Consequently,
one would expect that it would be possible to increase reso-
lution and power to detect IBD by including genotype data
for a large number of rare variants.
We compared power of BEAGLE, GERMLINE, and
PLINK on the Illumina data, aggregating results over the
four regions. Table 3 shows the results. To ensure that
GERMLINE would have the opportunity to detect regions
as short as 1 cM, we ran GERMLINE with a minimum
length threshold equal to 0.2 cM smaller than the size
of the inserted IBD (e.g., 0.8 cMminimum when detecting
the 1 cM regions, 1.8 cMwhen detecting the 2 cM regions).
This will tend to overestimate GERMLINE’s power for the
small segments, because one would normally run this
programwith a much higher threshold, such as the default
5 cM. With low thresholds on segment size in GERMLINE,
the false-positive rates are quite high (Table 2), and hence
the false discovery rate will also be high (false discovery
rates are given below). We see that, except for the short
regions (1 cM) with GERMLINE, the power of BEAGLE is
signiﬁcantly higher than that of GERMLINE or PLINK,
even for the larger 4 cM regions that are relatively easy to
detect, and despite BEAGLE’s much lower false-positive
rate.
Figure 3 shows HBD power with BEAGLE. For HBD
power, we investigated the same regions and panels.
Comparing Figure 3 to Figure 2, we see that HBD powererican Journal of Human Genetics 86, 526–539, April 9, 2010 531
Table 3. Comparison of Power across BEAGLE, GERMLINE,
and PLINK for Illumina 550K European Data
Size of
Artificial IBD BEAGLE GERMLINE
PLINK
(Default)
PLINK
(Relaxed)a
1 cM 14 28 0 1
2 cM 52 47 0 13
3 cM 82 60 7 46
4 cM 95 67 46 80
5 cM 98 63 71 90
Reported power is the percentage of artificial IBD segments detected.
a See Material and Methods for parameters used in the relaxed PLINK run.
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Figure 2. Power to Detect IBD with BEAGLE
Four sizes of IBD segments are considered, and these are labeled at the top of the plot. Four different regions of the genome are inter-
rogated, and these are labeled at the bottom of the plot. Two SNP arrays plus their union (‘‘Combined’’) are considered for each segment
size and region. Each bar is the proportion detected out of 30 artiﬁcial IBD segments.is somewhat higher than IBD power. This is not surprising,
given that there is no haplotype-phase uncertainty in the
HBD segments. In Figure 2 and Figure 3, we can see several
instances where the estimated detection power decreases
with the use of the combined data-set versus only one of
the panels. Stochastic differences in the population haplo-
type-frequency model between the different marker sets
could explain the occasional lower estimated detection
power in the combined data.
With no phase uncertainty, Browning1 reported approx-
imately 80% power to detect IBD segments of size 1 cM. In
contrast, we ﬁnd IBD power of approximately 15% and
HBD power of approximately 25% for this size region.
Phase uncertainty reduces IBD-detection power. However,
it should not affect HBD-detection power. The main expla-
nation for this difference is the difference in prior IBD
probabilities between the two studies, although several
other factors may have contributed to the difference.
Browning1 used a larger prior IBD probability, of 0.001,
as compared to the current study (0.0001). To investigate
this factor, we reran HBD detection, using this higher prior
HBD probability for HBD segments of size 1 cM on Illu-
mina data in region 1A. This change to the prior increased
the rate of detection of 1 cM HBD segments to 50% from
22%. Thus, our conservative choice of prior in this work
explains a large part of the difference in results between
this work and the earlier work.1 Clearly, the choice of prior
plays an important role in the trade-off between power and
false-positive IBD detection. The choice of marker panel
and the accuracy of the genetic map could also be contrib-
uting factors. Browning1 used simulated data and data
from the Affymetrix 500K panel over chromosomes 1
and 22. Differences in marker density and other character-
istics of the marker panel certainly affect power to detect
IBD. However, Browning1 found power > 70% for 1 cM
segments over a range of simulated marker densities and
over the two chromosomes.532 The American Journal of Human Genetics 86, 526–539, April 9, 2As well as being able to detect the presence of IBD
segments, we wish to estimate their endpoints. Figure 4
shows the amount of over- or underestimation of the
endpoints for detected IBD segments with BEAGLE. Here,
the deﬁnition of the boundary of the estimated IBD
segment is given as the ﬁrst position for which the poste-
rior IBD probability exceeds 0.5 through to the last such
contiguous position. The estimated IBD segment tends to
be smaller than the actual IBD segment. Where the esti-
mated IBD segment extends into the surrounding non-
IBD background, the length that it does so is typically fairly
short. If one changes the deﬁnition of the estimated IBD
region to include positions on either side until the poste-
rior IBD probability ﬁrst drops below 0.1, the picture
reverses (data not shown), with amounts of missed IBD
tending to be signiﬁcantly smaller than amounts of overes-
timated IBD. With this alternative deﬁnition, for detected
IBD segments of size 1 cM, the amount of missed IBD
has median 0.008 cM and maximum 0.13 cM. Whereas
BEAGLE tends to underestimate the lengths of the IBD
regions, PLINK and GERMLINE tend to overestimate, by
an average of 0.2 to 0.6 cM for PLINK (depending on region
size and default or relaxed settings) and 0.6 to 0.8 cM for010
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Figure 3. Power to Detect HBD with BEAGLE
Four sizes of HBD segments are considered, and these are labeled at the top of the plot. Four different regions of the genome are inter-
rogated, and these are labeled at the bottom of the plot. Two SNP arrays plus their union (‘‘Combined’’) are considered for each segment
size and region. Each bar is the proportion detected out of 60 artiﬁcial HBD segments.GERMLINE. It is not surprising that methods with a rela-
tively high false-positive rate will tend to overestimate
IBD-segment size.
IBD and HBD Discovery in the 1958 British
Birth Cohort
We tested 100,000 randomly selected pairs of individuals
from the 58BC data for IBD in the four regions with
BEAGLE. Figure 5 shows the lengths of the detected
segments. For this histogram, we deﬁne estimated IBD
length as the length over which the posterior IBD proba-
bility remains above 0.5. This will tend to slightly underes-
timate the length of the actual IBD segment (see Figure 4).
All lengths greater than 5cM (from regions 1A and 2A only)
are truncated to 5cM in the histogram, for comparability
with results from regions 1B and 2B, which have total
length 5cM.
The mean length of IBD segments detected with the
Affymetrix data is 2.26 cM, and there are 287 detected
segments (total length 647 cM); the mean length of IBD
segments detected with the Illumina data is 1.99 cM, and●●
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The Amthere are 552 detected segments (total length 1098 cM);
the mean length of IBD segments detected with the
combined data is 1.93 cM, and there are 616 detected
segments (total length 1188 cM). Thus, detection of recent
IBD is signiﬁcantly (approximately 70%) better with Illu-
mina 550K data than with Affymetrix 500K data for the
four regions examined, and detection of recent IBD is
slightly (approximately 8%) better with the combination
of the two sets of data compared with Illumina 550K
data only.
Figure 6 directly compares lengths of IBD segments
found by using the Affymetrix 500K and Illumina 550K
platforms. In the left panel, we see that where an IBD
segment is found by using both platforms, the estimated
lengths are in good agreement (the correlation is 0.94),
although the estimated lengths from Illumina 550K tend
to be slightly higher than those from the Affymetrix
500K data for these segments (mean 2.82 cM for Illumina
550K and 2.70 cM for Affymetrix 500K). In the center
and right panels, we see that the IBD segments not found
by using one platform tend to be short, although even●
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Figure 4. Under- and Overestimation of
IBD Segments Detected in Illumina 550K
Data with BEAGLE
For detected IBD segments of given size
(x axis), the left plot shows the amount of
the IBD segment with posterior IBD proba-
bility < 0.5, whereas the right plot shows
the distance over which the posterior IBD
probability remained > 0.5 beyond the
boundaries of the IBD segment. The plots
are box plots: the thick black line gives
the median, the box gives the upper and
lower quartiles, the ‘‘whiskers’’ extend to
the furthest data point that is no more
than 1.5 times the interquartile range
from the box, and outlying points beyond
the whiskers are individually plotted.
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Figure 5. Estimated Lengths of IBD Segments Detected in 58BC Data with BEAGLE
The rightmost bar in each plot includes all estimated segment lengths > 4.5 cM. IBD segments were detected in the four regions
described in Table 1. The left panel shows lengths of segments detected with the use of Affymetrix 500K data, the center panel shows
lengths of segments detected with Illumina 550K data, and the right panel shows lengths of segments detected with the union of the two
SNP chips. A total of 100,000 randomly selected pairs of individuals were analyzed.some IBD segments as large as 5 cM are found by using one
platform but not the other. The mean length of IBD
segments found by using Affymetrix data but not Illumina
data is 1.4 cM, whereas the mean length of IBD segments
found by using Illumina data but not Affymetrix data is
1.6 cM.
Overall, we tested 100,000 pairs over 40 cM (the com-
bined length of the four regions), and we found 1188 cM
IBD with the combined data, which corresponds to an
average rate of detected IBD of 3.0 per 10,000 (2.7 per
10,000 with the Illumina data). This estimate is based on●
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Figure 6. Comparison of Lengths of IBD Segments Detected with
Platform Only
The results are based on IBD detected in 100,000 random pairs of ind
panel shows detected lengths on both platforms of IBD segments de
550K data (there are 188 such segments). The center and right panels
the use of Affymetrix 500K data but not with Illumina 550K data (ce
Affymetrix 500K data (right panel; 364 segments).
534 The American Journal of Human Genetics 86, 526–539, April 9, 2only 40 cM selected from the genome, so these rates are
imprecise estimates of genomic rates of IBD detectability.
We used a prior IBD probability of 1 per 10,000, which
is thus seen to be conservative for these data. Figure 7
shows IBD detection over the four regions. The detection
rate is lower at the ends of the regions because there is
less information at the ends. For the Illumina data, the
IBD-detection rate stays mostly between 2.0 and 4.5 per
10,000.
The increased resolution of our method is important for
ﬁnding increased amounts of IBD. Although we foundfymetrix 500K only
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Figure 7. Total IBD Detected with BEAGLE across Each of the Four Regions
A total of 100,000 pairs of individuals were tested.1188 cM IBD in total by using the combined data, only 230
cM of that was from IBD segments of length 4 cM or
greater, whereas 483 cM of it was from IBD segments of
length 2 cM or less.
We tested all individuals in the 58BC data with geno-
types on both platforms (1373 individuals) for HBD with
BEAGLE over all autosomal chromosomes. Whereas it is
not computationally feasible to test all pairs of individuals
for IBD over all autosomal chromosomes for these data
(due to the quadratic nature of testing all pairs), it is
feasible to apply HBD detection on this scale. The total
amount of detected HBD (adding all estimated segment
lengths) was 2263 cM for Affymetrix (comprising 566
HBD segments) versus 2351 cM for Illumina (comprising
657 HBD segments). Although the total amounts of HBD
are fairly close, they represent a signiﬁcant number of
smaller segments (< 2 cM) detected by Illumina but not
by Affymetrix, as seen by examination of the histograms
in Figure 8.Affymetrix 500K
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Figure 8. Estimated Lengths of HBD Segments Detected in 58BC D
The rightmost bar in each plot includes all estimated segment length
the use of Affymetrix 500K data, whereas the right panel shows length
1373 individuals with genotypes on both platforms.
The AmWe found ﬁve instances (two in the Affymetrix data and
three in the Illumina data) for which two HBD segments in
an individual were separated by a non-HBD gap of < 1 cM.
Because such gaps are improbable under our HBD prior
model, we investigated these to determine the cause. In
particular, we looked at the number of heterozygous geno-
types within the gap region on both platforms and
whether the gap remained after increasing the number of
runs to 10 (from 5). Table 4 shows the results. One of the
gaps (gap 5) appeared to be due to an insufﬁcient number
of runs. The other gaps involved heterozygous genotypes,
and thus reﬂected properties of the data. Small clusters
of heterozygous genotypes located within an HBD region
(whether resulting in a non-HBD gap or not) could be
due to correlated genotype errors (gaps 1–3) or to a struc-
tural event, such as a double crossover that occurred in
one of the historical meioses linking the two shared haplo-
types (gaps 1–4). Table 4 suggests that when the number of
heterozygous genotypes is low (1–2), the genotype errorIllumina 550K
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Table 4. Investigation of Non-HBD Gaps < 1 cM between HBD Segments Detected with BEAGLE
Gap No.
Platform on which
Gap Was Found
Size of
Gap (cM)
Disappeared when Doubling
the Number of Runs
No. of Heterozygous Genotypes
on Platform with Gap
No. of Heterozygous Genotypes
on Alternate Platform
1 Affymetrix 0.17 No 3 0
2 Affymetrix 0.63 No 3 0
3 Illumina 0.38 No 3 0
4 Illumina 0.27 No 5 2
5 Illumina 0.58 Yes 0 0modeling allows for the HBD region to extend across the
region, whereas if the number is larger (3 or more) the
method inserts a non-HBD gap. We did not ﬁnd any
similar gaps in IBD in the IBD discovery study, but this
may be because the examined regions were too small. If
a small cluster of genotypes indicative of non-IBD occurred
near the end of the analyzed region, it would probably
simply curtail the discovered IBD segment rather than
result in an additional short segment of discovered IBD.
The HBD-discovery analysis also allows examination of
the success or otherwise of the genotype error modeling,
as heterozygous genotypes are inconsistent with HBD. In
the Illumina data, there were 12 HBD segments containing
one heterozygous genotype, whereas there were no HBD
segments containing more than one heterozygous geno-
type. In the Affymetrix data, there were 18 HBD segments
containing one heterozygous genotype, there were four
Affymetrix HBD segments containing two heterozygous
genotypes, and there was one Affymetrix HBD segment
containing three heterozygous genotypes. Thus, our
method is successful in extending HBD across genotype
errors, provided that the overall weight of evidence for
HBD is sufﬁciently high. We expect that the error model-
ing is also working successfully in the IBD detection,
although it is more difﬁcult to verify this.
The genotype error modeling allows the HBD to extend
across some double heterozygotes in an individual. These
double heterozygotes may represent correlated genotype
errors in some cases. The genotypes were called with
BEAGLECALL, which makes use of LD.16 Using LD when
calling genotypes improves overall genotype accuracy,
but it could yield correlated genotype errors at tightly
linked markers in a sample. In order to check whether
correlated genotype errors are a plausible explanation, we
looked at the corresponding genotypes as called by
CHIAMO17 (Affymetrix data) or GenCall (Illumina data).
Because these methods do not utilize LD, they are less
likely to produce correlated genotype errors (although
their overall error rate is higher). We found that correlated
genotype error could explain some, but not all, of the ﬁve
clusters of heterozygous genotypes in HBD segments
that we found in the Affymetrix HBD data, but it does
not explain either of the heterozygous clusters found in
the Illumina HBD segments. The model of IBD and HBD
is not designed to allow for correlated genotype errors.536 The American Journal of Human Genetics 86, 526–539, April 9, 2However, these are fairly rare events, and thus ignoring
them should be acceptable in most applications.
We looked for individuals with high genomic levels of
HBD with the use of the Illumina 550K data. The highest
level of genomic HBD (percentage of autosomal SNPs with
P(HBD) > 0.5) was 7.1%. Two individuals had > 5%, six
had>3%, and sevenhad>1%genomicHBD.Of1373 indi-
viduals, 435 had some HBD detected (i.e., posterior proba-
bility of HBD > 0.5 somewhere in their genome). The
mean amount of HBD was 4.7 per 10,000 individuals (per
position). When the individuals with > 1% HBD were
removed, the mean amount of HBD dropped to 2.6 per
10,000. One individual was HBD for almost all of chromo-
some 13 (there was some heterozygosity in the ﬁrst few
hundred SNPs but not for the remainder of the chromo-
some) but was not HBD elsewhere in the genome. This is
presumably a cell-line artifact.28 Figure 9 shows the geno-
mic patterns of HBD for the ﬁve individuals with the high-
est levels of HBD (> 3%), excluding the individual with the
chromosome 13 artifact. From the ﬁgure, one can see that
the HBD and non-HBD boundaries are quite clear (on this
scale), with the probabilities quickly moving from 0 to 1.
This pattern is also seen in IBD data (not shown).
Assessment of False Discovery Rates
Using the results from the false-positive and power anal-
yses, as well as from the detection study, we can estimate
false discovery rates for the UK European population. We
expect that false discovery rates would be similar in other
outbred European populations, such as individuals of
European descent in the USA. Rates for the Illumina data
were estimated as described in Material and Methods,
and results are shown in Table 5. These estimates are
approximate, because they are calculated from limited
data. It is also important to note that the composite indi-
viduals constructed for the false-positive analysis may be
more difﬁcult to phase than a typical individual because
of the reduction in IBD sharing with other individuals in
the sample. This could affect false-positive rates for
BEAGLE and for GERMLINE (but not for PLINK, because
it does not utilize LD information). We see that BEAGLE
has a low false discovery rate (< 1%), even for segments
1–2 cM in length. In contrast, GERMLINE and PLINK
have much higher false discovery rates for the small
segment sizes, and PLINK has a high false discovery rate010
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Figure 9. Genomic HBD Probabilities
from BEAGLE for Five Individuals with
the Highest Genomic Levels of HBD
Individual (A) has 7.1% of autosomal SNPs
with P(HBD) > 0.5, (B) has 3.2%, (C) has
3.6%, (D) has 6.4%, (E) has 3.5%. Results
are from data on the Illumina 550K plat-
form. The dotted vertical lines are the
chromosome boundaries.even for large segments. For a 50% false discovery rate (half
of reported segments are false), one would consider
segments of a length of R 3 cM for GERMLINE and of
any length (R 1 cM) for BEAGLE or PLINK. If a lower false
discovery rate, such as 10%, were desired, one might
consider segments of a length of R 4 cM for GERMLINE
and of any length (R 1 cM) for BEAGLE. The default
5 cM threshold for GERMLINE seems reasonable, but one
could reduce it to 3 or 4 cM for this type of data. It is impor-
tant to consider power as well as false discovery rate. If two
methods have the same false discovery rate, one would
prefer the method with the higher power. With BEAGLE,
one can have high conﬁdence even in very small (1 cM)
reported IBD segments. Additionally, BEAGLE’s power to
detect segments over 2 cM in length is quite high.
Discussion
We have presented a new method for detection of recent
IBD or HBD in unrelated individuals. Our method is imple-The American Journal of Humamented in the freely available BEAGLE
software package (version 3.2). The
method is, to our knowledge, the ﬁrst
method that fully accounts for LD,
which allows increased resolution of
detection and enables much more
IBD to be detected. For example,
when using the Illumina 550K data,
only 21% of the total length of IBD
that we found was contained in
segments of length > 4 cM. Greater
power to detect IBD will lead to
increased power for IBD mapping, as
well as to increased accuracy from
IBD-based genotype imputation and
phasing.6
Current IBD resolution may be
somewhat restricted by the relative
scarcity of low-frequency variants on
existing SNP arrays. We found that
increasing the number of SNPs in
a region, by combining the Illumina
550K and Affymetrix 500K panels,
did not greatly increase the amount
of IBD detected. However, rare vari-
ants can provide greater evidence for
IBD than common variants. Thus,analysis of sequence data, or of data from panels with
more rare SNPs as well as the common SNPs, will probably
further improve resolution and power to detect small IBD
segments.
We found that power to detect HBD is much higher than
power to detect IBD of the same segment length. This is
because phase uncertainty can reduce power to detect
IBD, but there is no phase uncertainty in HBD regions,
because HBD regions consist of homozygous genotypes.
In a large sample, an iterative approach will be possible,
in which detected IBD will be used to obtain highly accu-
rate haplotypes for the individuals with IBD, which will
allow improved detection of IBD, further improving the
resolution of our method.
By creating composite individuals, we constructed a data
set on which to compare false-positive rates of IBD
segment detection. We found that PLINK and GERMLINE
had much higher rates of false-positive results than
BEAGLE, as well as having lower power, and, consequently,
their false discovery rates were very high for small ton Genetics 86, 526–539, April 9, 2010 537
Table 5. Estimated False Discovery Rates, per Locus, for Northern
European Samples Genotyped on the Illumina 550K Array
False Discovery Rate
IBD Size bTa BEAGLE GERMLINE PLINK(Default) PLINK(Relaxed)
1-2 cM 2.7e-4 0.004 0.86 N/Ab 0.37
2-3 cM 9.7e-5 0 0.60 0.23 0.46
3-4 cM 5.3e-5 0 0.12 0.33 0.37
4-5 cM 3.2e-5 0 0 0.33 0.30
a Estimated rate of true IBD of this size, per locus.
b When false-positive rate and power are both 0, the false discovery rate is
undefined.moderately sized segments (< 5 cM for PLINK and < 3 cM
for GERMLINE). For large IBD segments (> 5 cM), we
expect that all methods would have good power and low
false discovery rates, but for small segments, BEAGLE is
clearly superior in both respects. In an outbred population,
a high proportion of the detectable (with BEAGLE, or
a similarly high-powered method) IBD will be found in
small segments. Thus, being able to detect small segments
of IBD will greatly increase the usefulness of IBD-based
approaches.
In this work, we controlled false-positive IBD detection
by use of a very stringent prior distribution. Indeed, our
prior probabilities of IBD are lower than the rates of IBD
that we found in a UK European population. Our false
discovery rates are extremely small, and thus, depending
on the application, one might wish to increase the prior
probability of IBD somewhat, in order to achieve an
increase in power. For example, by increasing the prior
probability of HBD from 1 in 10,000 to 1 in 1000, we
were able to increase the power to detect HBD segments
of a length of 1 cM from 22% to 50%.
It is computationally expensive to apply our IBD-detec-
tion method to all pairs of individuals in large samples.
Running BEAGLE for IBD detection with ten runs on
approximately 13,000 pairs on chromosome 1 Illumina
550K data took 600 hr of computing time. PLINK took
5 min to do the same analysis. GERMLINE took < 7 min
to analyze all 887,778 pairs, not including the phasing
time, which took around 3 hr with BEAGLE. Thus, running
PLINK or GERMLINE on a genome-wide data set is feasible,
whereas at present BEAGLE IBD can be applied only to
a restricted number of pairs (such as several thousand
pairs over the whole genome) or to candidate regions. It
is possible to apply the BEAGLE HBD detection on a
genome-wide scale (e.g., we applied it to data with approx-
imately 500K SNPs and 1500 individuals), because the
number of individuals is much fewer than the number of
all pairs of individuals. For those problems for which
BEAGLE is computationally feasible, the greatly improved
accuracy and power justiﬁes the increased computing
requirements. We expect that it will be possible to apply
our IBD detection method comprehensively over the538 The American Journal of Human Genetics 86, 526–539, April 9, 2whole genome for a large data set if we develop a computa-
tionally efﬁcient preﬁlter, so that IBD probabilities are
calculated only on pairs of individuals for which the data
are suggestive of IBD at a given location. We are currently
working on such a ﬁlter, with encouraging preliminary
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